Vitiligo and COVID-19 vaccine Links and more Health ConditionsHealth ConditionsAlzheimer's & DementiaAnxietyArthritisAsthma & AllergiesBreast CancerCancerCardiovascular HealthCOVID-19Dermatology & SkincareDiabetesEnvironment & SustainabilityExercise & FitnessEye HealthHeadache & MigraineHealth EquityHIV & AIDSHuman BiologyInflammatory Bowel DiseaseLeukemiaLGBTQIA+Men's HealthMental HealthMultiple Sclerosis (MS)NutritionParkinson's DiseasePsoriasisSexual HealthWomen's HealthDiscoverNewsLatest NewsOriginal SeriesMedical MythsHonest NutritionThrough My EyesNew Normal HealthPodcastsHow to understand chronic painWhat is behind vaccine hesitancy?The amazing story of hepatitis C, from discovery to cureNew directions in dementia researchCan psychedelics rewire a depressed, anxious brain?Why climate change matters for human healthToolsGeneral HealthDrugs A-ZHealth HubsHealth ToolsBMI Calculators and ChartsBlood Pressure Chart: Ranges and GuideBreast Cancer: Self-Examination GuideSleep CalculatorHealth ProductsAffordable Therapy OptionsBlood Pressure MonitorsDiabetic SuppliesFitness TrackersHome GymsGreen Cleaning ProductsHow to Shop for CBDQuizzesRA Myths vs FactsType 2 Diabetes: Managing Blood SugarAnkylosing Spondylitis Pain: Fact or FictionConnectAbout Medical News TodayWho We AreOur Editorial ProcessContent IntegrityConscious LanguageNewslettersSign UpFollow UsMedical News TodayHealth ConditionsDiscoverToolsConnectSubscribe Vitiligo and COVID-19 vaccine Links and moreMedically reviewed by Amanda Caldwell, MSN, APRN-C — By Carolyn Farnsworth on July 13, 2022Recent evidence has shown that COVID-19 vaccination may correlate with the onset or worsening of vitiligo. Share on PinterestJasmin Merdan/Getty ImagesAll data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub for the most recent information on the COVID-19 pandemic. Vitiligo is an autoimmune condition involving skin pigmentation or color loss. A person with vitiligo develops patches of skin with little or no pigmentation across their body. The Centers for Disease Control and Prevention (CDC) recommend COVID-19 vaccination for all 6 months or older. COVID-19 vaccines are effective in preventing the disease or minimizing its symptoms. However, these vaccines may cause side effects and trigger certain conditions, such as vitiligo. Despite this, doctors still advise people to receive a vaccination to reduce the risk of severe illness from COVID-19. Keep reading to learn more about how COVID-19 vaccination works and the potential link between vitiligo and COVID-19 vaccines. How COVID-19 vaccines work The main COVID-19 vaccines include:Pfizer-BioNTechModernaJohnson & Johnson’s Janssen This section will review how these vaccines work and what side effects they may cause. Pfizer-BioNTech and Moderna Both the Pfizer-BioNTech and Moderna vaccines are messenger RNA (RNA) vaccines. This type of vaccine delivers artificial genetic material to the body. This genetic material, mRNA, contains instructions for building a certain protein, which causes an immune response in the body. The body creates antibodies in response to this immune activation. If an individual later contracts SAR-CoV-2 — the virus that causes COVID-19 — they will already have antibodies in their body to fight this infection. Antibodies will help them fight SAR-CoV-2 or minimize the symptoms of COVID-19. Johnson & Johnson s Janssen Johnson & Johnson s Janssen vaccine is a vector vaccine. This vaccine delivers an artificial, harmless virus to the body. Health experts call this artificial virus a vector virus. After it enters the body, this vector virus also instructs cells to create a new type of protein. Like in mRNA vaccines, this protein causes an immune response in the body, which produces antibodies that can help fight off SAR-CoV-2 in the future. Can the COVID-19 vaccine cause vitiligo In rare instances, individuals have developed certain skin changes, such as vitiligo, after receiving a COVID-19 vaccine. Scientists believe this occurrence may relate to the effect of vaccination on melanocytes. Melanocytes are the cells responsible for giving skin its color and contain the pigment melanin. After a COVID-19 vaccination, new immune cells may attack melanocytes in rare cases, leading to the onset of vitiligo. Recent studies of vitiligo cases Different vaccines across different age groups have triggered the development of vitiligo following the COVID-19 vaccination. Both a 58-year-old man who received the Pfizer-BioNTech vaccine and a 61-year-old woman who had the Moderna vaccine developed vitiligo. These cases emphasize that the COVID-19 vaccines may be among the list of triggers for vitiligo since it causes an extreme inflammatory response. A 33-year-old woman also developed vitiligo after the first dose of the Pfizer-BioNTech vaccine. Another case of vitiligo occurred in a 13-year-old girl who received the same vaccine. Both of these individuals had a family history of vitiligo. Researchers believe that the COVID-19 vaccine may induce people to develop vitiligo, which already has a genetic susceptibility to the skin condition. However, this adverse skin reaction should not deter eligible candidates from receiving a vaccination. The risk of these mild and manageable reactions is small compared with the possible risks of developing COVID-19. Can the COVID-19 vaccine worsen vitiligo Although cases of vitiligo worsening after a COVID-19 vaccine are rare, they do occur. Scientists believe that people with a history of the condition have a higher risk of adverse reactions to the vaccine. Researchers identified a 22-year-old man who experienced worsening vitiligo following his first dose of the Pfizer-BioNTech vaccine. Two weeks after vaccination, his patches of vitiligo began to worsen. In this case, the researchers hypothesized that this resulted from antibodies produced by the man’s body in response to his COVID-19 vaccination. These antibodies may compound the effects of melanocyte-attacking antibodies. In another case, a 64-year-old woman developed lichen planus after receiving the second dose of the Pzifer vaccine. Lichen planus is a condition that can cause rashes across the skin’s surface. This woman had had vitiligo for 30 years before she developed lichen planus. The rashes due to this condition appeared on the parts of her skin that the vitiligo had affected. As she experienced this after both vaccine doses, researchers believe the vaccine caused it. Although the vast majority of people who receive a COVID-19 vaccine will not experience worsening vitiligo, additional studies are necessary to determine how and why this occurs in rare cases. Symptoms Vitiligo symptoms can vary widely between individuals. Some of the most common symptoms include: patches of milky-white skin on areas such as the face, hands, arms, and feet loss of pigmentation on the inside of the mouth or nose hair that has turned white In some rare cases, people with vitiligo may also experience swelling or inflammation in the eyes or ears. Some individuals with the condition may only develop a few patches or spots throughout the body. Others may experience more generalized patches that affect larger parts of their bodies. In rare cases, vitiligo may cause a total loss of pigment in all skin cells. Vitiligo occurs similarly in people of all races but may be more noticeable in individuals with darker skin. Read more about vitiligo on black skin. Possible side effects of COVID-19 vaccination Most people who receive a COVID-19 vaccine will experience only mild side effects. These possible side effects may include: discomfort, redness, or inflammation around the vaccination sitefeelings of tirednessnauseafever or chillsmuscle sorenessheadaches Usually, these side effects are not severe and resolve within a few days. In extremely rare cases, individuals can experience more extreme side effects, such as anaphylaxis, a severe allergic reaction. For example, a small number of people who received the Johnson and Johnson’s Janssen vaccine developed blood clots. The Food and Drug Administration (FDA) reported that this occurs at a rate of 3.23 per million doses of vaccine administered. Cases of myocarditis also occurred more in male adolescents and young adults after the Pfizer-BioNTech or Moderna vaccines. However, most people who received care responded well to treatment. Treatment There is no ideal treatment for vitiligo. A dermatologist considers the most suitable treatment plan for each person. Doctors may prescribe topical or oral medications or recommend laser treatments for people with the condition. Ultimately, decisions surrounding vitiligo treatment are highly personal. People with vitiligo may choose not to treat their condition or seek effective alternative treatment options such as dietary changes. Summary COVID-19 vaccines are highly effective in preventing COVID-19 or minimizing its symptoms. In extremely rare cases, a COVID-19 vaccine may cause or worsen vitiligo. Further studies must determine why this happens and who might be at risk. Although doctors cannot cure vitiligo, treatment options are available for individuals with this condition. Last medically reviewed on July 13, 2022DermatologyMelanoma / Skin CancerCOVID-19 22 sourcescollapsedMedical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references. We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.Beatty, A. L., et al. (2021). Analysis of COVID-19 vaccine type and adverse effects following vaccination.https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2787361/beatty_2021_oi_211132_1639512983.78595.pdfBukhari, A. E. (2022). New-onset of vitiligo in a child following COVID-19 vaccination.https://www.jaadcasereports.org/article/S2352-5126(22)00106-0/pdfCiccarese, G. (2021). Sudden onset of vitiligo after COVID-19 vaccine [Letter].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646249/pdf/DTH-9999-e15196.pdfCoronavirus (COVID-19) update: FDA limits use of Janssen COVID-19 vaccine to certain individuals [Press release]. (2022).https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individualsCOVID vaccine-induced lichen planus on areas previously affected by vitiligo [Letter]. (2021).https://grimalt.net/wp-content/uploads/2021/10/jdv.17687.pdfDe Domingo, B., et al. (2022). Vogt-Koyanagi-Harada disease exacerbation associated with COVID-19 vaccine.https://mdpi-res.com/d_attachment/cells/cells-11-01012/article_deploy/cells-11-01012-v2.pdf?version=1647516602Ezzedine, K., et al. (2015). Vitiligo [Abstract].https://www.sciencedirect.com/science/article/abs/pii/S0140673614607637Lichen planus. (2022).https://www.aad.org/public/diseases/a-z/lichen-planus-overviewMelanocyte. (n.d.).https://www.cancer.gov/publications/dictionaries/cancer-terms/def/melanocyteMilitello, M., et al. (2022). Vitiligo is possibly triggered by COVID-19 vaccination.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809499/pdf/cureus-0014-00000020902.pdfMyocarditis and pericarditis after mRNA COVID-19 vaccination. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.htmlPossible side effects after getting a COVID-19 vaccine. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.htmlOkan, G., et al. (2021). Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine.https://onlinelibrary.wiley.com/doi/10.1111/dth.15280Schmidt, C. (2020). Temprian therapeutics: Developing a gene-based treatment for vitiligo.https://www.nature.com/articles/d41586-020-01808-5Selected adverse events reported after COVID-19 vaccination. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.htmlStay up to date with your COVID-19 vaccines. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.htmlUnderstanding how COVID-19 vaccines work. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.htmlUnderstanding mRNA COVID-19 vaccines. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mRNA.htmlViral vector vaccines. (2022).https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/viralvector.htmlVitiligo. (2019).https://www.niams.nih.gov/health-topics/vitiligoVitiligo. (2022).https://medlineplus.gov/genetics/condition/vitiligo/Vitiligo: Diagnosis and treatment. (2022).https://www.aad.org/public/diseases/a-z/vitiligo-treatmentFEEDBACK:Medically reviewed by Amanda Caldwell, MSN, APRN-C — By Carolyn Farnsworth on July 13, 2022 Latest newsWhat sets 'SuperAgers' apart? Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affective disorder (SAD): How to beat it this fall and winterCDC: Monkeypox in the US 'unlikely to be eliminated in the near future'Why are more women prone to Alzheimer's? New clues arise Related CoverageVitiligo prevention: Is it possible?Medically reviewed by Owen Kramer, MD Vitiligo causes patches of skin to lose their color. Certain treatments and strategies may keep these patches from growing. Learn more here.READ MORERinvoq: How does it work? The FDA recently approved Rinvoq for some people with atopic dermatitis. Rinvoq is a Janus kinase inhibitor. Here, we learn how these drugs work.READ MOREFDA approves Rinvoq for atopic dermatitis: The details The FDA recently approved Rinvoq to treat people 12 years and older with moderate-to-severe atopic dermatitis (AD) who did not respond to other…READ MORE